Phospho-RAB8A (Thr72) Antibody [A18L3]

Application: Reactivity: Mouse

Lane 1: MEF, Lane 2: MEF (MLi-2, 100 nM, 90 min)

Usage Information

Dilution
WB1:1000

Application
WB

Reactivity
Mouse

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
24 kDa

Datasheet & SDS

Biological Description

Specificity
Phospho-RAB8A (Thr72) Antibody [A18L3] detects endogenous levels of total RAB8A protein only when it is phosphorylated at Thr72.

Clone
A18L3

Synonym(s)
MEL; RAB8; RAB8A; Ras-related protein Rab-8A; Oncogene c-mel

Background
Phospho-RAB8A (Thr72), the LRRK2-catalyzed modification within the switch II helix of this small GTPase of the Rab family, serves as a critical rheostat coupling kinase signaling to polarized membrane trafficking, ciliogenesis, and metabolic adaptation across neurons, epithelial cells, and adipocytes. LRRK2 hyperactivation, as in Parkinson's disease mutants, phosphorylates Thr72 to disrupt Rabin8 GEF activity while recruiting RILPL2 effector binding, which sequesters GTP-Rab8A from membrane engagement and redirects it to lysosomal lipid storage pathways; this phosphorylation locks Rab8A in a conformation that impairs GTP hydrolysis and effector interactions essential for primary cilia assembly and GLUT4 vesicle exocytosis. In polarized epithelia, pThr72-Rab8A limits BBSome-mediated IFT trafficking, shortening cilia length while promoting Golgi retention of apical cargo like sucrase-isomaltase, whereas insulin stimulation transiently activates Rab8A via AS160 dephosphorylation to drive GLUT4 translocation independently of Thr72 status. The modification integrates LRRK2 signaling with ciliary hedgehog/Wnt pathways, where phospho-null T72A mutants restore ciliogenesis in LRRK2 G2019S cells, while phosphomimetic T72D phenocopies disease-associated trafficking defects. Thr72 phosphorylation calibrates neuronal dendrite outgrowth through optineurin-mediated autophagy and adipocyte lipid droplet biogenesis during nutrient excess, positioning it as a precise pharmacodynamic biomarker for researchers quantifying LRRK2 pathway engagement via Phos-tag gels or proximity ligation assays in iPSC-derived midbrain organoids.

Background

Phospho-RAB8A (Thr72), the LRRK2-catalyzed modification within the switch II helix of this small GTPase of the Rab family, serves as a critical rheostat coupling kinase signaling to polarized membrane trafficking, ciliogenesis, and metabolic adaptation across neurons, epithelial cells, and adipocytes. LRRK2 hyperactivation, as in Parkinson's disease mutants, phosphorylates Thr72 to disrupt Rabin8 GEF activity while recruiting RILPL2 effector binding, which sequesters GTP-Rab8A from membrane engagement and redirects it to lysosomal lipid storage pathways; this phosphorylation locks Rab8A in a conformation that impairs GTP hydrolysis and effector interactions essential for primary cilia assembly and GLUT4 vesicle exocytosis. In polarized epithelia, pThr72-Rab8A limits BBSome-mediated IFT trafficking, shortening cilia length while promoting Golgi retention of apical cargo like sucrase-isomaltase, whereas insulin stimulation transiently activates Rab8A via AS160 dephosphorylation to drive GLUT4 translocation independently of Thr72 status. The modification integrates LRRK2 signaling with ciliary hedgehog/Wnt pathways, where phospho-null T72A mutants restore ciliogenesis in LRRK2 G2019S cells, while phosphomimetic T72D phenocopies disease-associated trafficking defects. Thr72 phosphorylation calibrates neuronal dendrite outgrowth through optineurin-mediated autophagy and adipocyte lipid droplet biogenesis during nutrient excess, positioning it as a precise pharmacodynamic biomarker for researchers quantifying LRRK2 pathway engagement via Phos-tag gels or proximity ligation assays in iPSC-derived midbrain organoids.

References
https://pubmed.ncbi.nlm.nih.gov/32017888/ https://pubmed.ncbi.nlm.nih.gov/29482628/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%